ANIXA BIOSCIENCES, INC. Treasury Stock, Shares, Acquired
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- ANIXA BIOSCIENCES, INC. treasury stock, shares, acquired for the quarter ending 2015-10-31 was 60.23K shares.
- ANIXA BIOSCIENCES, INC. treasury stock, shares, acquired for the quarter ending 2015-07-31 was -768.00K shares.
- ANIXA BIOSCIENCES, INC. treasury stock, shares, acquired for fiscal 2015 was 92.23K shares.
| Period end | Treasury Stock, Shares, Acquired 3 month | Treasury Stock, Shares, Acquired 12 month |
|---|---|---|
| 2015-10-31 | 60.23K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-08 | 92.23K shares 10-K · filed 2016-12-08 |
| 2015-07-31 | -768.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |